Inhaled vasolidators;Inhalierte vasodilatatoren

Anaesthesist

Volumn 51, Issue 8, 2002, Pages 603-624

  Zwissler, B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aerosol; Hypoxaemia; Inhaled vasodilators; Nitric oxide; Prostacyclin; Pulmonary hypertension

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; MUCOLYTIC AGENT; NITRATE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN E1; STEROID; VASODILATOR AGENT;

AEROSOL; ANESTHESIA; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPOXEMIA; INTENSIVE CARE; LUNG ALVEOLUS HYPOVENTILATION; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; LUNG VENTILATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN PERIOD; NONHUMAN; PULMONARY HYPERTENSION; REVIEW; VASODILATATION;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; PNEUMONIA; PROSTAGLANDINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; RESPIRATORY DISTRESS SYNDROME, ADULT; VASODILATOR AGENTS;

EID: 0036672827     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0370-1     Document Type: Review

References (209)

1. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation
2. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome
3. A prospective trial of inhaled nitric oxide in clinical lung transplantation
4. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
5. Inhaled nitric oxide attenuates reperfusion injury in non-heartbeating-donor lung transplantation
6. Perioperative use of inhaled nitric oxide for heart and lung transplantation
7. Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease
8. Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery
9. Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system
10. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury
11. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury
12. Response to inhaled nitric oxide in patients with acute right heart syndrome
13. Aerosolised prostacyclin for pulmonary hypertension in neonates
14. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep
15. Hemodynamic and gas exchange response to inhaled nitric oxide and prone positioning in acute respiratory distress syndrome patients
16. Pulmonary response of normal human subjects to inhaled vasodilator substances
17. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension
18. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects
19. 2 auf die linksventrikuläre kontraktilität in vivo
20. Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion
21. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery
22. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation
23. Inhaled nitric oxide delivery by anesthesia machines
24. Endotracheal administration of tolazoline in hypoxia-induced pulmonary hypertension
25. Inhaled nitric oxide reduces human lung allograft dysfunction
26. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease
27. Intraoperative inhaled nitric oxide during anesthesia for lung transplant
28. Inhaled aerosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation
29. Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome. Inability to translate physiologic benefit to clinical outcome in adult clinical trials
30. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
31. Effect of inhaled prostacyclin in combination with almitrine on ventilation-perfusion distributions in experimental lung injury
32. Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome
33. Nebulized prostacyclin (PGI-2)in acute respiratory distress syndrome: Impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response
34. Sequential histamine inhalations cause increased bronchial histamine reactivity in guinea pigs: Role of platelets, thromboxanes and prostacyclin
35. Aerosolized prostacyclin and inhaled nitric oxide in septic shock - Different effects on splanchnic oxygenation
36. Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism
37. Anticoagulative effect of nitric oxide inhalation in ARDS
38. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension
39. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
40. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
41. Inhaled nitric oxide after lung ischemia reperfusion; effect on hemodynamics and oxygen free radical scavenger system
42. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome
43. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
44. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx
45. Additive effect of nitric oxide inhalation on the oxygenation benefit of the prone position in the adult respiratory distress syndrome
46. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD
47. Combined nitric oxide inhalation, prone positioning and almitrine infusion improve oxygenation in severe ARDS
48. In haled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
49. Vasodilators in persistent pulmonary hypertension of the newborn: A need for optimal appraisal of efficacy
50. Intratracheal prostacyclin for resuscitation in primary pulmonary hypertension
51. Eight hours inhalation of prostacyclin (PGI2) in healthy lambs: Effects on tracheal, bronchial, and alveolar morphology
52. Inhalation of prostacyclin (PGI2) for eight hours does not produce signs of acute pulmonary toxicity in healthy lambs
53. Use of inhaled nitric oxide perioperatively and intensive care patients
54. Individual lung blood flow during unilateral hypoxia: Effects of inhaled nitric oxide
55. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study
56. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
57. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension
58. Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects
59. Bronchoconstrictor and antibroncho-constrictor properties of inhaled prostacyclin in asthma
60. Inhaled nitric oxide in cardiology practice
61. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia
62. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS
63. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study
64. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension
65. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
66. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
67. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn
68. Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension
69. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury
70. Positive end-expiratory pressure and response to inhaled nitric oxide: Changing nonresponders to responders
71. Prone positioning and inhaled nitric oxide: Synergistic therapies for acute respiratory distress syndrome
72. The activity of a new, novel inhibitor of leukotriene synthesis in rhesus monkey Ascaris reactors
73. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome
74. Usefulness of nitric oxide treatment for pulmonary hypertensive infants during cardiac anesthesia
75. Inhaled endothelin A antagonist improves arterial oxygenation in experimental acute lung injury
76. Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation
77. Inhalation of selective pulmonary: Effects on myocardial contractility
78. Searching for the ideal inhaled vasodilator: From nitric oxide to prostacylin
79. Aerosol production and aerosol droplet size distribution during mechanical ventilation (IPPV) with a new ultrasonic nebulizer
80. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease
81. The increased left ventricular contractility by the prostaglandin 12 analogue epoprostenol is mediated by cyclic adenosine monophosphate (cAMP)
82. Intra-operative use of inhaled vasodilators: Are there indications?
83. Efficacy of inhaled prostanoids in experimental pulmonary hypertension
84. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats
85. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation
86. Effects of NO inhalation on porcine cerebral hemodynamics and oxygenation
87. Treatment of a case of acute right heart failure by inhalation of iloprost, a long acting prostacyclin analogue
88. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure
89. Selective reduction of PVR by inhalation of a cGMP analogue in a porcine model of pulmonary hypertension
90. Effects of iloprost, a stable prostacyclin analog, on intestinal leukocyte adherence and microvascular blood flow in rat experimental endotoxemia
91. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
92. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome
93. The effects of inhaled nitric oxide, gabexate mesilate, and retrograde flush in the lung graft from non-heart beating minipig donors
94. Induction of chromosome aberrations in peripheral blood lymphocytes after short time inhalation of nitric oxide
95. Inhalation of nitric oxide in acute lung injury: Results of a European multicentric study
96. Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device
97. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension
98. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome
99. Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model
100. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension
101. Use of nebulised prostacyclin to ascertain reversibility of secondary pulmonary hypertension
102. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease
103. Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin
104. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure
105. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS
106. Aerosolized prostacyclin in acute respiratory distress syndrome caused by Chlomydiaceae spp. pneumonia
107. Electroencephalogram changes during inhalation with nitric oxide in the pediatric intensive care patient - A preliminary report
108. Effect of inhaled nitric oxide on hemodynamics and Va/Q inequalities with chronic obtructive pulmonary disease
109. Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease
110. Causes of mortality in patients with adult respiratory distress syndrome
111. Adenosine as a vasodilator in primary pulmonary hypertension
112. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease
113. Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit
114. 2 during one-lung ventilation in patients undergoing thoracoscopic procedures
115. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease
116. Inhaled nitric oxide and pentoxifylline in rat lung transplantation from non-heart-beating donors
117. High-dose nitric oxide inhalation increases lung injury after gastric aspiration
118. Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension
119. Effect of inhaled nitric oxide on cardiovascular response to catecholamine in heart failure
120. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension
121. Structural organization and chromosomal assignment of the human prostacyclin receptor gene
122. Combination of inhaled nitric oxide therapy and inverse ratio ventilation in patients with sepsis-associated acute respiratory distress syndrome
123. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
124. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost
125. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial
126. Endotracheal inhalatory sodium nitroprusside in severely hypoxic newborns
127. Does norepinephrine modify the effects of inhaled nitric oxide in septic patients with acute respiratory distress syndrome?
128. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome
129. Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: Effect of noradrenalin
130. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome
131. 1α by inhalation
132. Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome
133. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension
134. Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients
135. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension
136. Inhaled sodium nitroprusside. A non selective reduction of thromboxane analogue-induced pulmonary vasoconstriction in healthy sheep
137. Cardiopulmonary effects of aerosolized prostaglandin E-1 and nitric oxide inhalation in patients with acute respiratory distress syndrome
138. Inhaled nitric oxide in acute respiratory failure
139. Pharmacologic approach of hypoxemia in ARDS patients
140. Inhaled nitric oxide in acute respiratory failure: Dose-response curves
141. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome
142. Low dose inhaled nitric oxide causing selective pulmonary vasodilation in child with idiopathic pulmonary hypertension
143. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS
144. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects of pulmonary capillary pressure and ventilation-perfusion distributions
145. Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation
146. Inhaled nitric oxide: Selective pulmonary vasodilation in cardiac surgical patients
147. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: Vasodilator capacity and cellular mechanisms
148. Reflex tracheal contraction evoked in dogs by bronchodilator prostaglandins E2 and I2
149. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
150. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin
151. Inhaled nitric oxide administration during one-lung ventilation in patients undergoing thoracic surgery
152. Effect of inhaled norepinephrine on the nitroglycerin-induced bronchodilatation in asthmatics
153. Inhaled nitric oxide for the adult respiratory distress syndrome
154. Efficacy of inhaled nitric oxide in patients with severe ARDS
155. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome
156. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease
157. Inhaled nitric oxide for the adult respiratory distress syndrome
158. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
159. Prostacyclin aerosol in an infant with pulmonary hypertension
160. Prostacyclin (PGI2): New aspects of an old substance in the treatment of critically ill patients
161. Inhaled nitric oxide in a patient with severe pulmonary embolism
162. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
163. Inhaled nitric oxide for high-altitude pulmonary edema
164. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery
165. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension
166. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure
167. Aerosolisiertes prostazyklin zur präoperativen evaluation und postkardiochirurgischen behandlung von patienten mit pulmonaler hypertension
168. The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs
169. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure
170. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: A dose-response study and comparison with prostacyclin
171. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension
172. Inhaled nitric oxide in patients with normal and increase pulmonary vascular resistance after cardiac surgery
173. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients
174. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient
175. Inhaled nitric oxide: Basic biology and clinical applications
176. Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung
177. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent
178. Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man
179. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation
180. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
181. Inhaled nitric oxide: Clinical applications, indications, and toxicology
182. Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine
183. Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study
184. Inhaled nitric oxide in the management of pulmonary hypertension after congenital cardiopathies surgery
185. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: Incidence, clinical implications, and prognosis
186. Aerosolised prostacyclin in adult respiratory distress syndrome
187. Effects of aerosolized prostacyclin in severe pneumonia: Impact of fibrosis
188. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome
189. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension
190. The acute respiratory distress syndrome
191. Bronchodilator effects of prostacyclin (PGI2) in dogs and guinea pigs
192. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia
193. PGI2-aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction
194. Prostacyclin aerosol and inhaled nitric oxide failed to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs
195. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension
196. Nitric oxide inhalation in acute pulmonary hypertension after cardiac surgery reduces oxygen concentration and improves mechanical ventilation but not mortality
197. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension
198. Inhaled nitric oxide (40 ppm) during one-lung ventilation, in the lateral decubitus position, does not decrease pulmonary vascular resistance or improve oxygenation in normal patients
199. Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation
200. Renal effects of inhaled nitric oxide in humans
201. Inhaled nitric oxide in acute respiratory failure in adults
202. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets
203. Das akute rechtsherzversagen. Ätiologie - Pathophysiologie - Diagnostik - Therapie
204. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass
205. Effects of inhaled prostacyclin (PGI2) as compared to inhaled nitric oxide (NO) in a canine model of pulmonary microembolism and oleic acid edema
206. 2) as compared to inhaled nitric oxide (NO) on right ventricular performance in hypoxic pulmonary vasoconstriction
207. Inhaled vasodilatory drugs and gases
208. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide (NO) in adult respiratory distress syndrome (ARDS)
209. Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury